Predictors of Failure of Non-invasive Ventilation and High Flow Nasal Cannula
NCT ID: NCT05864898
Last Updated: 2023-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2023-07-01
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predicting Success of HFNC: The Utility of the ROX Index
NCT02834325
Assessment Of Different Indices in Prediction of Noninvasive Ventilation Failure in Patients With Acute Respiratory Failure
NCT05850195
A Novel Index to Predict the Failure of High-flow Nasal Cannula in Patients with Acute Hypoxemic Respiratory Failure
NCT05549882
NIV in Covid-19 Respiratory Failure
NCT05020691
ROX Index Versus MROX Index to Predict Treatment Outcome for High Flow Nasal Cannula And/or Noninvasive Ventilation in Patients with Respiratory Failure
NCT06715644
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There are Many factors to predict early failure but World still searching for new factors and comparing between each ;in order to eatablish best one that achieve the least mortality rate.
Little studies about effiecacy of HACOR Score as a predictor of failure in HFNC patients.
Little studies about effiecacy of ROX Index as a predictor of failure in NIV ventilating patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. RR \> 25 cycle / min
2. using accessory muscles and paradoxical breath.
3. PaO2 / FiO2 ratio \< 300
Exclusion Criteria
2. Contr-indication of NIV like untreated Pneumothorax.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hussein Makarem
Resident doctor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIV and HFNC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.